Synageva BioPharma (GEVA) Commences $80 Million Common Stock Offering
Tweet Send to a Friend
Synageva BioPharma (NASDAQ: GEVA) has commenced a $80 million underwritten public offering of shares of its common ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
